We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAR
13576
CALL
DELISTED
Eargo, Inc. Common Stock
EAR
$2.69K ﹤0.01%
+1,040
New +$2.46K
INN
13577
PUT
Summit Hotel Properties
INN
$747M
$2.69K ﹤0.01%
400
RGLS
13578
PUT
DELISTED
Regulus Therapeutics
RGLS
$2.69K ﹤0.01%
2,100
+2,000
+2,000% +$2.66K
BIAFW icon
13579
bioAffinity Technologies
BIAFW
$112K
$2.68K ﹤0.01%
24,381
-1,337
-5% -$117
HYFM icon
13580
PUT
Hydrofarm Holdings
HYFM
$9.15M
$2.66K ﹤0.01%
290
-440
-60% -$4.24K
DVYE icon
13581
PUT
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$2.65K ﹤0.01%
100
-9,000
-99% -$223K
TPST icon
13582
CALL
Tempest Therapeutics
TPST
$14.2M
$2.64K ﹤0.01%
+46
New +$2.18K
HOLI
13583
PUT
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$2.63K ﹤0.01%
100
-22,900
-100% -$514K
MBOT icon
13584
PUT
Microbot Medical
MBOT
$122M
$2.62K ﹤0.01%
+1,600
New +$2.13K
CAPTW
13585
DELISTED
Captivision Inc Warrant
CAPTW
$2.62K ﹤0.01%
+40,088
New +$3.71K
CMCT
13586
CALL
Creative Media & Community Trust
CMCT
$13M
0
INTZ
13587
PUT
DELISTED
INTRUSION INC NEW
INTZ
$2.61K ﹤0.01%
10,300
-600
-6% -$152
NKTR icon
13588
PUT
Nektar Therapeutics
NKTR
$2.46B
$2.6K ﹤0.01%
307
-2,813
-90% -$21.3K
DYAI icon
13589
PUT
Dyadic International
DYAI
$39.4M
$2.58K ﹤0.01%
1,600
+300
+23% +$514
RPT
13590
CALL
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$2.57K ﹤0.01%
200
-100
-33% -$1.14K
KINS icon
13591
CALL
Kingstone Companies
KINS
$294M
$2.56K ﹤0.01%
+1,200
New +$2.65K
NB
13592
PUT
NioCorp Developments
NB
$756M
$2.55K ﹤0.01%
+800
New +$2.89K
BNED icon
13593
PUT
Barnes & Noble Education
BNED
$447M
$2.53K ﹤0.01%
17
-86
-83% -$9.56K
TRS icon
13594
PUT
TriMas Corp
TRS
$1.45B
$2.53K ﹤0.01%
+100
New +$2.47K
LYEL icon
13595
CALL
Lyell Immunopharma
LYEL
$333M
$2.52K ﹤0.01%
65
-445
-87% -$16K
CDZI icon
13596
CALL
Cadiz
CDZI
$267M
$2.52K ﹤0.01%
900
-1,700
-65% -$5.13K
GAQ.WS
13597
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$2.52K ﹤0.01%
83,901
+305
+0.4% +$11
HYAC.WS
13598
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$2.52K ﹤0.01%
16,055
-270,659
-94% -$61.2K
TSHA icon
13599
PUT
Taysha Gene Therapies
TSHA
$1.78B
$2.48K ﹤0.01%
1,400
-31,300
-96% -$62.4K
ARKO icon
13600
CALL
ARKO Corp
ARKO
$840M
$2.48K ﹤0.01%
300
-1,900
-86% -$14.5K

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.